[In the Media] “Japan must face up to growing danger of drug-resistant germs” (NIKKEI ASIA, October 12, 2022)
date : 10/17/2022
Tags: AMR
On October 12, 2022, Nikkei Asia published an editorial by Mr. Ryoji Noritake, CEO and Board Member of Health and Global Policy Institute (HGPI) and Mr. Michael W. Hodin, CEO of the Global Coalition on Aging (GCOA), that was written in collaboration between HGPI and GCOA – “Japan must face up to growing danger of drug-resistant germs.”
The editorial addresses the situation of Antimicrobial Resistance (AMR) and related counter-measures in Japan, including four critical action areas to amend the Japan’s 2016-2020 National Action Plan on AMR. They include an establishment of pull-incentives, fostering greater collaboration among stakeholders through organizations like AMR Alliance Japan, a promotion of fundamental infectious disease control by vaccines and related measures, and strengthening testing and surveillance systems from the viewpoint of One Health.
For further information, please refer to the editorial
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)



